β2-AR /PCBP2相互作用在胰腺癌发生发展中的作用及机制
批准号:
81572397
项目类别:
面上项目
资助金额:
25.0 万元
负责人:
周国雄
依托单位:
学科分类:
肿瘤病因
结题年份:
2017
批准年份:
2015
项目状态:
已结题
项目参与者:
丁晓凌、张海峰、曹维、万春华、黄莉莉、蔡日欣、龚辰、王晓彤
中文摘要
长期的生活压力和精神紧张是胰腺癌的重要危险因素,其可通过肾上腺素受体通路发挥促癌作用。课题组前期研究发现β2-肾上腺素受体(β2-AR)可结合胞浆中的多聚胞嘧啶结合蛋白2(PCBP2),而PCBP2能够调节癌基因c-myc和K-ras的表达及促进胰腺癌细胞增殖。基于此,课题组提出假说:精神因素可通过β2-AR介导的PCBP2通路促进胰腺癌发展。本课题拟首先在胰腺癌临床组织中阐明β2-AR和PCBP2的表达关系;进而分析β2-AR和PCBP2的相互作用对下游c-myc和K-ras表达的调节作用,并研究此作用机制对胰腺癌细胞增殖能力的影响;最后在裸鼠动物模型中验证慢性焦虑通过β2-AR/PCBP2通路对胰腺癌发展的作用。该课题研究有助于阐明精神因素对胰腺癌的作用机制,并且能为胰腺癌的防治提供新的理论依据。
英文摘要
Chronic life pressure and mental stress is one of the significant risk factors for pancreatic cancer. β2-adrenergic receptor (β2-AR) on the surface of cancer cells plays the vital role in the oncogenesis of psychological factors. Our previous studies identified that β2-AR could combined with Poly(rC) Binding Protein 2 (PCBP2). Furthermore, PCBP2 could regulate the expression of c-myc and K-ras, and enhance pancreatic cancer cell proliferation. Based on this, we propose the hypothesis that psychological stress promotes the progression of pancreatic cancer via β2-AR-induced activation of PCBP2. In this project, we will detect the expression of β2-AR and PCBP2 in pancreatic cancer tissue sections, and analyze the association of the protein expression and clinicopathological parameters. Furthermore, we will explore the impact of β2-AR/PCBP2 interaction on the regulation of the expression of c-myc and K-ras, and exam the mechanism of facilitating cell growth ability. Finally, we will construct a subcutaneous xenograft model of pancreatic cancer which was exposed to social stress, in order to validate the results as the former. The project will clarify the molecular mechanisms of the effect of mental factors on pancreatic cancer development, and provide a theoretical basis for new prevention and treatment of pancreatic cancer.
长期的生活压力使机体处于持续的应激状态,交感-肾上腺髓质系统激活,其可通过肾上腺素受体通路促进胰腺癌的进展。课题组研究发现胰腺癌细胞表面β2-肾上腺素受体(β2-AR)活化后可募集胞浆中的多聚胞嘧啶结合蛋白2(PCBP2),两者相互结合后可促进下游分子c-myc的表达。β2-AR促进胰腺癌细胞增殖能力,该作用受β2-AR-PCBP2-c-myc信号通路介导。β2-AR和PCBP2在胰腺癌组织中高表达,并且与肿瘤的分化程度及临床分期相关。β2-AR/PCBP2高表达的胰腺癌患者预后较差。本研究结果初步明确了β2-AR/PCBP2复合物介导的神经信号通路对胰腺癌发展的作用机制,并将为胰腺癌的靶向治疗提供新的药物开发靶点。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma
DIXDC1 过度表达与人胰腺导管腺癌细胞生长增强和预后不良相关
DOI:
10.1016/j.humpath.2016.07.015
发表时间:
2016-11-01
期刊:
HUMAN PATHOLOGY
影响因子:
3.3
作者:
[Li, Xiaohong, Xiao, Ying, Wan, Chunhua]
通讯作者:
Wan, Chunhua
RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis
RACK1过度表达与胰腺导管腺癌生长和不良预后相关
DOI:
10.1016/j.yexmp.2016.08.001
发表时间:
2016-10-01
期刊:
EXPERIMENTAL AND MOLECULAR PATHOLOGY
影响因子:
3.6
作者:
[Li, Xiaohong, Xiao, Ying, Wan, Chunhua]
通讯作者:
Wan, Chunhua
β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression
β2-肾上腺素能受体信号传导通过促进 PCBP2 依赖性 c-myc 表达促进胰腺导管腺癌 (PDAC) 进展
DOI:
10.1016/j.canlet.2016.01.026
发表时间:
2016-01-01
期刊:
CANCER LETTERS
影响因子:
9.7
作者:
[Wan, Chunhua, Gong, Chen, Shen, Aiguo]
通讯作者:
Shen, Aiguo
表观遗传修饰的MHC-II基因细胞疫苗治疗胰腺癌的机理研究
-
批准号:81072028
-
项目类别:面上项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:周国雄
-
依托单位:
国内基金
海外基金